Related Experiment Video
Updated: May 26, 2026

Efficient Method for Imaging Murine Lungs that Preserves Spatial Dynamics of Fungal Spores in the Airways
Published on: December 13, 2024
Tracheobronchial manifestations of Aspergillus infections
Rafal Krenke1, Elzbieta M Grabczak
1Department of Internal Medicine, Pneumonology and Allergology, Medical University of Warsaw, 02-097 Warsaw, Poland. rkrenke@wum.edu.pl
Abstract:
Human lungs are constantly exposed to a large number of Aspergillus spores which are present in ambient air. These spores are usually harmless to immunocompetent subjects but can produce a symptomatic disease in patients with impaired antifungal defense. In a small percentage of patients, the trachea and bronchi may be the main or even the sole site of Aspergillus infection. The clinical entities that may develop in tracheobronchial location include saprophytic, allergic and invasive diseases. Although this review is focused on invasive Aspergillus tracheobronchial infections, some aspects of allergic and saprophytic tracheobronchial diseases are also discussed in order to present the whole spectrum of tracheobronchial aspergillosis. To be consistent with clinical practice, an approach basing on specific conditions predisposing to invasive Aspergillus tracheobronchial infections is used to present the differences in the clinical course and prognosis of these infections. Thus, invasive or potentially invasive Aspergillus airway diseases are discussed separately in three groups of patients: (1) lung transplant recipients, (2) highly immunocompromised patients with hematologic malignancies and/or patients undergoing hematopoietic stem cell transplantation, and (3) the remaining, less severely immunocompromised patients or even immunocompetent subjects.
Insights
Aspergillus spores can cause lung infections, particularly in immunocompromised individuals. This review details invasive Aspergillus airway diseases in different patient groups, including transplant recipients and those with hematologic malignancies.
Area of Science:
- Pulmonology
- Infectious Diseases
- Mycology
Background:
- Human lungs are exposed to Aspergillus spores daily.
- While typically harmless to healthy individuals, these spores can cause disease in those with weakened immune systems.
- Tracheobronchial aspergillosis, an infection of the airways, can manifest as saprophytic, allergic, or invasive disease.
Purpose of the Study:
- To review the spectrum of tracheobronchial aspergillosis.
- To focus on invasive Aspergillus airway infections.
- To differentiate clinical courses and prognoses based on predisposing conditions.
Main Methods:
- Review of existing literature on tracheobronchial aspergillosis.
- Categorization of invasive Aspergillus airway diseases by patient risk groups.
- Discussion of clinical presentation, course, and prognosis within these groups.
Main Results:
- Invasive Aspergillus tracheobronchial infections present differently across patient populations.
- Risk factors significantly influence the clinical course and outcomes.
- Three main patient groups are identified: lung transplant recipients, highly immunocompromised patients (hematologic malignancies/stem cell transplant), and less immunocompromised/immunocompetent individuals.
Conclusions:
- Understanding the specific patient context is crucial for managing invasive Aspergillus airway infections.
- Prognosis varies significantly based on the degree of immune compromise and underlying condition.
- Comprehensive management requires tailored approaches for different risk groups.
Related Concept Videos
Asthma III: Clinical Manifestations
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Asthma-III: Symptoms and Complications
Classification of Asthma
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
The Bronchial Tree
The trachea, commonly known as the windpipe, is a tube that connects the larynx (voice box) to the bronchi. At a point called the carina, it bifurcates into two primary bronchi. The right primary bronchus is wider, shorter, and more vertical than the left primary...
Asthma I: Introduction
